SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Israel races to build the next generation of Arrow missile defenses after Iran conflict

The Israel Innovation Authority is spearheading a $23.3M investment to establish an AI consortium for personalized medicine

Anthropic wants to disrupt drug discovery. Industry experts say the real challenge comes later

Rafael eyes Iron Dome interceptor production in India

Buzz

Most popular

Daily

Weekly

1

New pipeline clears path for Israel’s biggest gas export deal with Egypt

2

Qatar blocks Volkswagen's Iron Dome deal with Rafael as German plant faces closure

3

Rafael eyes Iron Dome interceptor production in India

4

Two Israeli quantum startups target Wall Street in multibillion-dollar SPAC deals

5

A startup led by Israeli air-defense veterans raises $36 million to tackle the growing threat of drone swarms

Equashield

1 stories about Equashield

Biotech company Equashield sells 25% stake to Nordic Capital at $1.3 billion valuation

06.10.22|Golan Hazani

CEO and co-founder Eric Shem-Tov is the largest shareholder at the company, which has registered sales in the hundreds of millions of dollars to hospitals across the world for its manual and automated solutions for the compounding and administration of hazardous drugs